RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 163 filers reported holding RIGEL PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $25,160 | +2.1% | 17,000 | 0.0% | 0.00% | -25.0% |
Q4 2023 | $24,650 | +34.3% | 17,000 | 0.0% | 0.00% | +33.3% |
Q3 2023 | $18,360 | -16.3% | 17,000 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $21,930 | -2.3% | 17,000 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $22,440 | -12.0% | 17,000 | 0.0% | 0.00% | -25.0% |
Q4 2022 | $25,500 | +27.5% | 17,000 | 0.0% | 0.00% | +33.3% |
Q3 2022 | $20,000 | +5.3% | 17,000 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $19,000 | -62.7% | 17,000 | 0.0% | 0.00% | -57.1% |
Q1 2022 | $51,000 | +13.3% | 17,000 | 0.0% | 0.01% | +16.7% |
Q4 2021 | $45,000 | -27.4% | 17,000 | 0.0% | 0.01% | -33.3% |
Q3 2021 | $62,000 | -16.2% | 17,000 | 0.0% | 0.01% | -35.7% |
Q2 2021 | $74,000 | +27.6% | 17,000 | 0.0% | 0.01% | +16.7% |
Q1 2021 | $58,000 | -3.3% | 17,000 | 0.0% | 0.01% | -14.3% |
Q4 2020 | $60,000 | +46.3% | 17,000 | 0.0% | 0.01% | +40.0% |
Q3 2020 | $41,000 | +32.3% | 17,000 | 0.0% | 0.01% | 0.0% |
Q2 2020 | $31,000 | +14.8% | 17,000 | 0.0% | 0.01% | -16.7% |
Q1 2020 | $27,000 | -25.0% | 17,000 | 0.0% | 0.01% | -7.7% |
Q4 2019 | $36,000 | +12.5% | 17,000 | 0.0% | 0.01% | +8.3% |
Q3 2019 | $32,000 | -27.3% | 17,000 | 0.0% | 0.01% | -29.4% |
Q2 2019 | $44,000 | 0.0% | 17,000 | 0.0% | 0.02% | -10.5% |
Q1 2019 | $44,000 | +12.8% | 17,000 | 0.0% | 0.02% | +18.8% |
Q4 2018 | $39,000 | -29.1% | 17,000 | 0.0% | 0.02% | -5.9% |
Q3 2018 | $55,000 | +14.6% | 17,000 | 0.0% | 0.02% | +6.2% |
Q2 2018 | $48,000 | -20.0% | 17,000 | 0.0% | 0.02% | -27.3% |
Q1 2018 | $60,000 | -9.1% | 17,000 | 0.0% | 0.02% | -29.0% |
Q4 2017 | $66,000 | +53.5% | 17,000 | 0.0% | 0.03% | +47.6% |
Q3 2017 | $43,000 | -6.5% | 17,000 | 0.0% | 0.02% | -19.2% |
Q2 2017 | $46,000 | – | 17,000 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CM Management, LLC | 1,500,000 | $1,620,000 | 1.72% |
Soleus Capital Management, L.P. | 14,803,015 | $15,987,256 | 1.48% |
ARMISTICE CAPITAL, LLC | 17,136,000 | $18,506,880 | 0.28% |
SPHERA FUNDS MANAGEMENT LTD. | 1,228,126 | $1,326,376 | 0.24% |
GSA CAPITAL PARTNERS LLP | 971,441 | $1,049 | 0.09% |
NJ State Employees Deferred Compensation Plan | 200,000 | $216,000 | 0.03% |
Providence Wealth Advisors, LLC | 27,500 | $29,013 | 0.03% |
XTX Topco Ltd | 164,238 | $177,377 | 0.03% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 3,369,076 | $3,638,602 | 0.02% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,151,765 | $1,243,906 | 0.02% |